Products in Pharmaceutical Actives & Precursors: Vitamin Source

Pharm-Rx D-Panthenol is a vitamin source that functions as Vitamin B5. This ingredient is commonly used in pharma and nutraceutical products.

Pharm-Rx Cyanocobalamin 1% provides Vitamin B12 sourced from Cyanocobalamin. Ideal for pharma and nutraceutical products, this ingredient supports various functions.

Pharm-Rx Thiamine Mono is a vital Vitamin B1 source for food and pharmaceutical products. Essential for various functions, this ingredient is crucial for pharma and nutraceuticals.

Veer-Chemie Niacinamide is used in pharmaceutical, human nutrition, animal feed, cosmetics, treatment of type-i diabetes mellitus, and cancer therapy.

Veer-Chemie Niacin is an Active Pharmaceutical Ingredient (API) used for cholesterol reduction. It is used in human nutrition for food fortification and in bakery foods, health drinks, vitamin drinks. It is also used in animal feed fortification.

Veer-Chemie Niacinamide Ascorbate is an Active Pharmaceutical Ingredient (API).

Veer-Chemie Tocopheryl Nicotinate Moisturizes, acts as an Anti-Oxidant, improves Microcirculation & protects from UV rays. Used in Skin Care, Hair Care, Lip Care, Massage Creams, Skin Lightening and Brightening, Eyeliner, Shampoo & Conditioner, Toothpaste & Mouthwash.

Paricalcitol is an active Vitamin D2 analog for the Pharmaceutical industry. Paricalcitol is used for the treatment and prevention of secondary hyperparathyroidism associated with chronic kidney disease (CKD). It has been shown to reduce parathyroid hormone levels by inhibiting its synthesis and secretion.

Ergocalciferol PhEur/USP/BP - Vitamin D2 pure is used to ensure the right concentration of calcium and phosphorus in the blood. Ergocalciferol is used to treat and prevent bone growth disorders such as osteomalacia, rickets and osteoporosis. Recent research shows that vitamin D2 can also be of paramount importance to prevent other abnormalities and diseases as well. Several forms of cancer and auto-immune diseases are targeted by several research companies. Vitamin D2 can also be used as starting material for APIs.

Alfacalcidol PhEur/IP/BP is a Vitamin D3 analog for the Pharmaceutical and Veterinary industry. Alfacalcidol is especially used to prevent and treat osteoporosis or decalcification of bones. The substance is also active against other bone growth disorders such as osteomalacia, rickets and specific liver and parathyroid glands abnormalities. It is also used for the treatment and prevention of secondary hyperparathyroidism associated with chronic kidney disease (CKD).

Calcifediol is a vitamin D3 analog for the Pharmaceutical and Veterinary industry. Calcifediol is especially used to prevent and treat osteoporosis or decalcification of bones. The substance is also active against other bone growth disorders such as rickets, osteomalacia and specific liver and parathyroid glands abnormalities. It is also used for the treatment and prevention of secondary hyperparathyroidism associated with chronic kidney disease (CKD).

Ercalcidiol is an active Vitamin D2 analog for the Pharmaceutical industry. Ercalcidiol can be used for the treatment of disorders in Calcium and Phosphor homeostasis. It can also be used as a marker for Vitamin D3 catabolism and a predictor of serum 25-hydroxycholecalciferol response to Vitamin D3 supplementation.

Secalciferol is an active Vitamin D analog for the Pharmaceutical industry. Secalciferol can be used for the treatment of disorders in Calcium and Phosphor homeostasis. It can also be used as a marker for Vitamin D3 catabolism and a predictor of serum 25-hydroxycholecalciferol response to Vitamin D3 supplementation.

Calcitriol is a vitamin D3 analog for the Pharmaceutical and Veterinary industry. Calcitriol is especially used to prevent and treat osteoporosis or decalcification of bones. The substance is also active against other bone growth disorders such as osteomalacia, rickets and specific liver and parathyroid glands abnormalities. It is also used for the treatment and prevention of secondary hyperparathyroidism associated with chronic kidney disease (CKD).